![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Pharma/fine chemicals roundup—5 February11:02 AM MST | February 5, 2013 | Deepti Ramesh Johnson Matthey reports lower quarterly sales Johnson Matthey reported a 2% year-on-year decrease in group sales, excluding precious metals, to £635 million ($998 million), for its fiscal third quarter ended 31 December 2012. The company announced the figures in an interim management statement. Johnson Matthey's fine chemicals division made steady progress with sales up 2%, to £63 million. Operating profit increased slightly compared with the year-earlier quarter but was lower than in the previous quarter, the company says. Lonza restructures... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|